Table 2: Bivariate and multivariate logistic regression analysis of determinant factors associated with diabetic complications at TASH, Addis Ababa, Ethiopia.
Variables |
Diabetic Complications, n (%) |
Bivariate logistic regression |
Multivariate logistic regression |
|||||
Yes |
No |
COR |
P-Value |
AOR |
(95%CI) |
p-value |
||
Gender |
Female |
43 (23.1) |
143 (76.9) |
1 |
|
1 |
|
|
Male |
77 (44) |
98 (56) |
2.6 |
≤ 0.01 |
2.6 |
(1.59, 4.25) |
≤ 0.01* |
|
Age |
< 30 |
7 (17.9) |
32 (82.1) |
1 |
- |
|
- |
0.426 |
30-60 |
69 (30.7) |
156 (69.3) |
0.5 |
0.11 |
0.806 |
(0.3, 2.2) |
0.670 |
|
> 60 |
44 (45.4) |
53 (54.6) |
0.3 |
≤ 0.01 |
0.585 |
(0.21, 1.7) |
0.316 |
|
Marital status |
Single |
15 (27.8) |
39 (72.2) |
1 |
- |
|
- |
- |
Married |
85 (32.6) |
176 (67.4) |
0.8 |
0.39 |
|
- |
- |
|
Divorced |
3 (50) |
3 (50) |
0.4 |
0.27 |
|
- |
- |
|
Widowed |
17 (42.5) |
23 (57.5) |
0.5 |
0.14 |
|
- |
- |
|
Residence |
Urban |
111 (33.2) |
223 (66.8) |
1 |
|
|
- |
- |
Rural |
9 (33.3) |
18 (66.7) |
1.0 |
0.99 |
|
- |
- |
|
Educational status |
No formal education |
22 (33.3) |
44 (66.7) |
1 |
0.33 |
|
- |
- |
Primary |
58 (38.2) |
94 (61.8) |
0.8 |
0.5 |
|
- |
- |
|
Secondary |
24 (27.9) |
62 (72.1) |
1.3 |
0.47 |
|
- |
- |
|
Tertiary |
16 (28.1) |
41 (71.9) |
1.3 |
0.53 |
|
- |
- |
|
Type of Diabetes Mellitus |
Type 1 |
12 (20.7) |
46 (79.3) |
1 |
|
|
- |
- |
Type 2 |
108 (35.6) |
195 (64.4) |
0.47 |
0.03 |
0.52 |
(0.23, 1.18) |
0.12 |
|
Duration of Diabetes Mellitus (years) |
< 5 |
22 (29.7) |
52 (70.3) |
1 |
0.01 |
|
- |
0.93 |
6-10 |
41 (26.1) |
116 (73.9) |
1.2 |
0.57 |
1.2 |
(0.23, 6.6) |
0.81 |
|
> 10 |
57 (43.8) |
73 (56.2) |
0.5 |
0.05 |
0.94 |
(0.11, 8.20) |
0.96 |
|
Duration of Treatment (years) |
< 5 |
23 (29.1) |
56 (70.9) |
1 |
0.01 |
|
- |
0.92 |
6-10 |
43 (26.7) |
118 (73.3) |
1.1 |
0.7 |
0.84 |
(0.16, 4.4) |
0.84 |
|
> 10 |
54 (44.6) |
67 (55.4) |
0.5 |
0.03 |
0.65 |
(0.08, 5.50) |
0.69 |
|
Regular exercise |
Yes |
51 (34) |
99 (66) |
1 |
|
|
- |
- |
No |
69 (32.7) |
142 (67.3) |
1.1 |
0.8 |
|
- |
- |
|
Social drug use |
Yes |
19 (39.6) |
29 (60.4) |
1 |
|
|
- |
- |
No |
101 (32.3) |
212 (67.7) |
1.4 |
0.32 |
|
- |
- |
|
BMI |
Underweight |
2 (13.3) |
13 (86.7) |
1 |
0.44 |
|
- |
- |
Normal |
56 (35.4) |
102 (64.6) |
0.28 |
0.1 |
|
- |
- |
|
Overweight |
43 (32.8) |
88 (67.2) |
0.32 |
0.14 |
|
- |
- |
|
Obese |
19 (33.3) |
38 (66.7) |
0.31 |
0.15 |
|
- |
- |
|
Comorbidities |
Yes |
71 (39) |
111 (61.0) |
1 |
|
|
- |
- |
No |
49 (27.4) |
130 (72.6) |
1.7 |
0.02 |
1.5 |
(0.92, 2.5) |
0.10 |
|
FBS |
< 126 |
18 (26.1) |
51 (73.9) |
1 |
|
|
- |
- |
≥ 126 |
102 (34.9) |
190 (65.1) |
0.66 |
0.16 |
1.3 |
(0.6, 2.6) |
0.52 |
|
HbA1c |
< 7 |
13 (15.9) |
69 (84.1) |
1 |
|
|
- |
- |
≥ 7 |
107 (38.4) |
172 (61.6) |
2.3 |
≤ 0.01 |
2.34 |
(1.4, 6.3) |
≤ 0.01* |